You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sovaldi

Showing 26 - 50 of 101
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic HCV Infection Trial in China (SOF, DAG181)

Completed
  • Chronic HCV Infection
  • Beijing, Beijing, China
  • +16 more
Mar 16, 2020

Hepatitis C, Chronic, HIV CDC Category A1 Trial in San Francisco (Sofosbuvir + Simeprevir)

Withdrawn
  • Hepatitis C, Chronic
  • HIV CDC Category A1
  • Sofosbuvir + Simeprevir
  • San Francisco, California
    San Francisco General Hospital, University of California, San Fr
Jun 11, 2019

Sovaldi-based Regimens in Mexico With Chronic Hepatitis C Virus

Completed
  • HCV Infection
  • Sovaldi
  • Cuernavaca, Mexico
  • +5 more
Sep 28, 2018

Hepatitis C, Cirrhosis Trial in Coronado (daclatasvir, Sofosbuvir, Sovaldi, Ribavirin)

Completed
Has Results
  • Hepatitis C
  • Cirrhosis
  • Coronado, California
    Southern California Research Center
Apr 23, 2019

Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir)

Completed
  • Hepatitis C Virus Infection
  • Birmingham, Alabama
  • +137 more
Mar 14, 2022

Hepatitis E, Hepatitis Chronic Viral Trial in Hanover, Berlin, Hamburg (Sofosbuvir)

Completed
  • Hepatitis E
  • Hepatitis Chronic Viral
  • Hanover, Lower Saxony, Germany
  • +2 more
Mar 7, 2019

Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

Terminated
Has Results
  • Hepatitis C
  • Simeprivir (SMV)
  • +2 more
  • Denver, Colorado
    University of Colorado Denver (Leprino Building)
Aug 16, 2021

Chronic HCV Infection Trial in China (SOF, DAG181)

Completed
  • Chronic HCV Infection
  • Beijing, Beijing, China
  • +34 more
Mar 16, 2020

Decompensated Cirrhosis Trial (Sofosbuvir 400mg (Sovaldi) + Daclatasvir 60 mg (Daklinza) + Ribavirin 200 mg (Rebetol), vitamin K

Completed
  • Decompensated Cirrhosis
  • Sofosbuvir 400mg (Sovaldi) + Daclatasvir 60 mg (Daklinza) + Ribavirin 200 mg (Rebetol)
  • vitamin K (Phytomenadione) 10 mg+ furosemide and spironolactone (Lasilactone) 50 mg + milk thistle (Silymarin) 140 mg + Albumin infusion
  • (no location specified)
Dec 3, 2018

Liver Disease Trial in New York, Dallas (sofosbuvir/ledipasvir, sofosbuvir, Ribavirin)

Terminated
Has Results
  • Liver Disease
  • New York, New York
  • +2 more
Jan 7, 2019

Hepatitis C Virus Infection Trial in Worldwide (SOF, RBV)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Los Angeles, California
  • +35 more
Apr 5, 2019

Chronic Hepatitis C Trial in Auckland, Christchurch (LDV/SOF, SOF, RBV)

Completed
Has Results
  • Chronic Hepatitis C
  • Auckland, New Zealand
  • +1 more
Oct 19, 2018

Hepatitis C Virus Infection Trial in China (Seraprevir, Sofosbuvir)

Unknown status
  • Hepatitis C Virus Infection
  • Beijing, Beijing, China
  • +21 more
Jun 27, 2019

COVID-19 Trial in Sao Paulo (Atazanavir, Daclatasvir 60 mg, Sofusbuvir + Daclastavir 60 mg)

Active, not recruiting
  • COVID-19
  • Sao Paulo, SP, Brazil
    Hospital do Coracao
Feb 25, 2022

Hepatitis C Trial in Australia, New Zealand (Sofosbuvir and ribavirin)

Completed
  • Hepatitis C
  • Sofosbuvir and ribavirin
  • Sydney, New South Wales, Australia
  • +4 more
Sep 19, 2018

End-Stage Renal Disease, Hepatitis C Trial in Baltimore (Zepatier, Ribavirin, Sofosbuvir)

Completed
Has Results
  • End-Stage Renal Disease
  • Hepatitis C
  • Baltimore, Maryland
    Johns Hopkins Hospital
Aug 8, 2018

Hepatitis C Virus Infection Trial in Japan (LDV/SOF, SOF, RBV)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Bunkyo, Japan
  • +36 more
Oct 19, 2018

Hepatitis C Virus Infection Trial (SOF/RBV/PegINFa-2)

Completed
  • Hepatitis C Virus Infection
  • (no location specified)
May 6, 2020

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (SOF+RBV, SOF+DCV, LDV/SOF)

Completed
  • Chronic Hepatitis C Infection
  • Beijing, Beijing, China
  • +1 more
Mar 16, 2018

HCV Infection Trial in New Zealand, Puerto Rico, United States (SOF, RBV, LDV/SOF)

Completed
Has Results
  • HCV Infection
  • San Francisco, California
  • +9 more
Jul 13, 2018

Hepatitis C Trial in Worldwide (SOF, VEL, RBV)

Completed
Has Results
  • Hepatitis C
  • Long Beach, California
  • +48 more
Oct 19, 2018

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (sofosbuvir and daclatasvir, ledipasvir/sofosbuvir)

Completed
  • Chronic Hepatitis C Infection
  • Beijing, Beijing, China
  • +1 more
Mar 16, 2018

Hepatitis C Virus Infection Trial in Puerto Rico, United States (SOF/VEL, SOF, RBV)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Long Beach, California
  • +50 more
Oct 19, 2018

Sovaldi® Plus Rebetol® in Japanese Chronic Genotype 2 Hepatitis

Completed
  • Hepatitis C
  • Ageo-shi, Japan
  • +44 more
Jul 28, 2017

Declatasvir in Egyptian Hepatitis C Virus Genotype 4

Unknown status
  • Hepatitis C
  • Daclatasvir 60 MG Oral Tablet [Daklinza]
  • +2 more
  • (no location specified)
Oct 8, 2017